Kymera Therapeutics Inc (KYMR)
R&D Expense Growth
21.72%
Quarterly · Period ending:
KYMR R&D Expense Growth
Latest reported21.72%period ending
Latest reported21.72%period ending
KYMR Quarterly R&D Growth (QoQ) (0.00% → 21.72%)
Latest values, visible window
High-resolution chart · PNG
KYMR r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 21.7182% | |
| 17.0504% | |
| 13.1846% | |
| -5.4779% | |
| -2.3263% | |
| 11.7493% | |
| 18.8826% | |
| 2.0405% | |
| 21.2684% | |
| -7.8365% | |
| 10.0858% | |
| 5.1347% | |
| 8.3833% | |
| -2.1005% | |
| -1.6956% | |
| 6.2577% | |
| 14.8815% | |
| -4.226% | |
| -2.0258% | |
| 8.7621% | |
| 35.6598% | |
| 27.3146% | |
| 29.2433% | |
| 14.1761% | |
| 14.0558% | |
| 9.291% | |
| -1.9805% | |
| 0% |